<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Infection and Immunity</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Infection and Immunity</journal-title><trans-title-group xml:lang="ru"><trans-title>Инфекция и иммунитет</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2220-7619</issn><issn publication-format="electronic">2313-7398</issn><publisher><publisher-name xml:lang="en">SPb RAACI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">275</article-id><article-id pub-id-type="doi">10.15789/2220-7619-2015-1-63-70</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">THE CELLULAR AND HUMORAL IMMUNITY STATE DEPENDING ON THE OUTCOME OF A WIDESPREAD PURULENT PERITONITIS</article-title><trans-title-group xml:lang="ru"><trans-title>СОСТОЯНИЕ КЛЕТОЧНОГО И ГУМОРАЛЬНОГО ИММУНИТЕТА В ЗАВИСИМОСТИ ОТ ИСХОДА РАСПРОСТРАНЕННОГО ГНОЙНОГО ПЕРИТОНИТА</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Savchenko</surname><given-names>A. A.</given-names></name><name xml:lang="ru"><surname>Савченко</surname><given-names>А. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p/><p/><p/><p>PhD, MD (Medicine), Professor, Head of the Laboratory of Molecular-Cell Physiology and Pathology, Scientific Research Institute of Medical Problems of the North, Krasnoyarsk, Russian Federation; </p></bio><bio xml:lang="ru"><p/><p/><p/><p>д.м.н., профессор, руководитель лаборатории молекулярно-клеточной физиологии и патологии ФГБНУ НИИ медицинских проблем Севера, г. Красноярск, Россия; </p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Borisov</surname><given-names>A. G.</given-names></name><name xml:lang="ru"><surname>Борисов</surname><given-names>А. Г.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p/><p/><p/><p>PhD (Medicine), Leading Researcher of the Laboratory of Molecular-Cell Physiology and Pathology, Scientific Research Institute of Medical Problems of the North, Krasnoyarsk, Russian Federation; </p></bio><bio xml:lang="ru"><p/><p/><p/><p>к.м.н., ведущий научный сотрудник лаборатории молекулярно-клеточной физиологии и патологии ФГБНУ НИИ медицинских проблем Севера, г. Красноярск, Россия; </p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Zdzitoveckij</surname><given-names>D. E.</given-names></name><name xml:lang="ru"><surname>Здзитовецкий</surname><given-names>Д. Э.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p/><p/><p/><p>PhD, MD (Medicine), Head of the Department of Surgical Diseases, Krasnoyarsk State Medical University, Krasnoyarsk, Russian Federation; </p></bio><bio xml:lang="ru"><p/><p/><p/><p>д.м.н., зав. кафедрой хирургических болезней им. проф. Ю.М. Лубенского ГБОУ ВПО Красноярский государственный медицинский университет им. проф. В.Ф. Войно-Ясенецкого МЗ РФ, г. Красноярск, Россия; </p></bio><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kudryavtsev</surname><given-names>I. V.</given-names></name><name xml:lang="ru"><surname>Кудрявцев</surname><given-names>И. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p/><p/><p/><p>PhD (Biology), Senior Researcher of the Department of Immunology, Research Institute of Experimental Medicine, St. Petersburg; Senior Researcher of the Biomedical School, Far Eastern Federal University, Vladivostok, Russian Federation. </p></bio><bio xml:lang="ru"><p/><p/><p/><p>к.б.н., старший научный сотрудник отдела иммунологии ФГБУ НИИ экспериментальной медицины СЗО РАМН, Санкт-Петербург; старший научный сотрудник школы биомедицины Дальневосточного федерального университета, г. Владивосток, Россия. </p></bio><email>igprek1981@yandex.ru</email><xref ref-type="aff" rid="aff3"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Scientific Research Institute of Medical Problems of the North, Krasnoyarsk, Russian Federation</institution></aff><aff><institution xml:lang="ru">ФГБНУ НИИ медицинских проблем Севера СО РАМН, г. Красноярск, Россия</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Krasnoyarsk State Medical University, Krasnoyarsk, Russian Federation</institution></aff><aff><institution xml:lang="ru">ГБОУ ВПО Красноярский государственный медицинский университет им. проф. В.Ф. Войно-Ясенецкого МЗ РФ, г. Красноярск, Россия</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">197376, Russian Federation, St. Petersburg, Acad. Pavlova str., 12, Scientific Research Institute of Experimental Medicine.&#13;
Far Eastern Federal University, Vladivostok, Russian Federation</institution></aff><aff><institution xml:lang="ru">197376, Россия, Санкт-Петербург, ул. Акад. Павлова, 12, ФГБУ НИИ экспериментальной медицины СЗО РАМН.&#13;
ФГАОУ ВПО Дальневосточный федеральный университет, г. Владивосток, Россия</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2015-04-21" publication-format="electronic"><day>21</day><month>04</month><year>2015</year></pub-date><volume>5</volume><issue>1</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>63</fpage><lpage>70</lpage><history><date date-type="received" iso-8601-date="2015-04-21"><day>21</day><month>04</month><year>2015</year></date><date date-type="accepted" iso-8601-date="2015-04-21"><day>21</day><month>04</month><year>2015</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2015, Savchenko A.A., Borisov A.G., Zdzitoveckij D.E., Kudryavtsev I.V.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2015, Савченко А.А., Борисов А.Г., Здзитовецкий Д.Э., Кудрявцев И.В.</copyright-statement><copyright-year>2015</copyright-year><copyright-holder xml:lang="en">Savchenko A.A., Borisov A.G., Zdzitoveckij D.E., Kudryavtsev I.V.</copyright-holder><copyright-holder xml:lang="ru">Савченко А.А., Борисов А.Г., Здзитовецкий Д.Э., Кудрявцев И.В.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://iimmun.ru/iimm/article/view/275">https://iimmun.ru/iimm/article/view/275</self-uri><abstract xml:lang="en"><p>The aim of the study was to examine the state of cellular and humoral immunity in patients with widespread purulent peritonitis (WPP) in depending on the disease outcome. The study involved 50 patients with community-acquired and hospital origin WPP. The testing of blood lymphocyte phenotype was performed by flow cytometry. The concentration of immunoglobulins and cytokines were measured by ELISA. It was established that the immune system state by WPP is characterized by leukocytosis, relative lymphopenia, increasing concentrations of pro-inflammatory cytokines, as well as decrease of the cytotoxic and activated T-lymphocytes content. The state of the cellular immunity in case of unfavorable outcome of the WPP is characterized by decreased of the γδT-lymphocytes and NKT-cells levels with increasing amounts of the B1-cells. The immune system state in case of a favorable outcome of the WPP is characterized by a decrease in the number of NK-cells in peripheral blood and increased levels of Th2-lymphocytes. Increasing of the Th2-cells number determines the increase in stimulating effects of T-cell on the humoral immunity, that is manifested in increasing concentrations of IL-4 and IgA, which is an important factor in the immunopathogenesis of the WPP determining its favorable outcome. </p></abstract><trans-abstract xml:lang="ru"><p>Целью исследования явилось изучение состояния клеточного и гуморального иммунитета у больных с распространенным гнойным перитонитом (РГП) в зависимости от исхода заболевания. Обследовано 50 больных РГП внебольничного и госпитального происхождения. Исследование фенотипа лимфоцитов крови проводили методом проточной цитометрии. Концентрацию иммуноглобулинов и цитокинов определяли иммуноферментным методом. Установлено, что состояние иммунной системы при РГП характеризуется лейкоцитозом, относительной лимфопенией, увеличением концентрации провоспалительных цитокинов, а также снижением содержания цитотоксических и активированных Т-лимфоцитов. Состояние клеточного звена иммунной системы при неблагоприятном исходе РГП характеризуется снижением уровней γδТ-лимфоцитов и NKT-клеток при повышении количества В1-лимфоцитов. Состояние иммунной системы при благоприятном исходе РГП характеризуется снижением количества NK-клеток в периферической крови и повышением содержания Th2-лимфоцитов. Увеличение количества Th2-клеток определяет усиление стимулирующего влияния Т-клеточного звена на гуморальный иммунитет, что проявляется в увеличении концентраций IL-4 и IgA, что и является важным фактором в иммунопатогенезе РГП, определяющим его благоприятный исход.</p></trans-abstract><kwd-group xml:lang="en"><kwd>immune system</kwd><kwd>peritonitis</kwd><kwd>T-lymphocyte</kwd><kwd>B-lymphocyte</kwd><kwd>cytokines</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>иммунная система</kwd><kwd>перитонит</kwd><kwd>Т-лимфоциты</kwd><kwd>В-лимфоциты</kwd><kwd>цитокины</kwd><kwd>иммуноферментный метод</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>1. Борисов А.Г. Клиническая характеристика нарушения функции иммунной системы // Медицинская иммунология. 2013. Т. 15, No 1. С. 45–50. [Borisov A.G. Clinical characteristics of dysfunction of the immune system. Meditsinskaya immunologiya = Medical Immunology (Russia), 2013, vol. 15, no. 1, pp. 45–50. (In Russ.)]</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>2. Земсков А.М., Земсков В.М. Дополнительные методы оценки иммунного статуса // Клиническая лабораторная диагностика. 1994. No 3. С. 34–35. [Zemskov A.M., Zemskov V.M. Additional methods for assessing of the immune status. Klinicheskaya laboratornaya diagnostika = Clinical Laboratory Diagnostics, 1994, no. 3, pp. 34–35. (In Russ.)]</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>3. Савельев В.С., Филимонов М.И., Гельфанд Б.Р., Подачин П.В., Бурневич С.З., Гиткович В.Е., Гайнулин Ш.М. Программируемый перитонеальный лаваж в лечении распространенного перитонита // Анналы хирургии. 1996. No 3. С. 25–29 [Savel’ev V.S., Filimonov M.I., Gel’fand B.R., Podachin P.V., Burnevich S.Z., Gitkovich V.E., Gajnulin S.M. Programmable peritoneal lavage in the treatment of widespread peritonitis. Annaly khirurgii = Annals of Surgery, 1996, no. 3, pp. 25–29. (In Russ.)]</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>4. Савченко А.А., Здзитовецкий Д.Э., Борисов А.Г., Лузан Н.А. Особенности состояния клеточного и гуморального иммунитета и уровни концентрации цитокинов у больных с распространенным гнойным перитонитом // Сибирское медицинское обозрение. 2013. No 1 (79). С. 24–28. [Savchenko A.A., Zdzitoveckij D.E., Borisov A.G., Luzan N.A. Features of the cellular and humoral immunity state and cytokine concentrations in patients with widespread purulent peritonitis. Sibirskoe meditsinskoe obozrenie = Siberian Medical Review, 2013, no. 1 (79), pp. 24–28. (In Russ.)]</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>5. Сарап П.В., Винник Ю.С., Останин А.А. Влияние иммунотропной терапии на структуру системообразующих показателей у пациентов с ургентной хирургической патологией // Вестник хирургии им. И.И. Грекова. 2012. Т. 171, No 4. С. 39–43. [Sarap P.V., Vinnik Ju.S., Ostanin A.A. Immunotropic influence on the structure of the backbone of therapy parameters in patients with urgent surgical pathology. Vestnik khirurgii im. I.I. Grekova = Herald of Surgery named after I.I. Grekov, 2012, vol. 171, no. 4, pp. 39–43. (In Russ.)]</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>6. Суковатых Б.С., Блинков Ю.Ю., Букреева А.Е., Ештокин С.А., Иванов П.А., Жуковский В.А. Применение иммобилизованных форм гипохлорита натрия в комплексном лечении распространенного гнойного перитонита // Вестник хирургии им. И.И. Грекова. 2011. Т. 170, No 6. С. 32–36. [Sukovatyh B.S., Blinkov Ju.Ju., Bukreeva A.E., Eshtokin S.A., Ivanov P.A., Zhukovskij V.A. The use of immobilized forms of sodium hypochlorite in the complex treatment of widespread purulent peritonitis. Vestnik khirurgii im. I.I. Grekova = Herald of Surgery named after I.I. Grekov, 2011, vol. 170, no. 6, pp. 32–36. (In Russ.)]</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>7. Хайдуков С.В., Байдун Л.А., Зурочка А.В., Тотолян Арег А. Стандартизованная технология «Исследование субпопуляционного состава лимфоцитов периферической крови с применением проточных цитофлюориметрованализаторов» (Проект) // Медицинская иммунология. 2012. Т. 14, No 3. С. 255–268. [Hajdukov S.V., Bajdun L.A., Zurochka A.V., Totoljan Areg A. Standardized technology «Research of lymphocytes subpopulation composition in peripheral blood using flow cytometry analyzers» (Draft). Meditsinskaya immunologiya = Medical Immunology (Russia), 2012, vol. 14, no. 3, pp. 255–268. (In Russ.)]</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>8. Ярилин А.А. Иммунология. М: ГЭОТАР-Медиа, 2010. 752 с. [Jarilin A.A. Immunologiya [Immunology]. Moscow: GEOTARMedia, 2010. 752 p.]</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>9. Amezcua Vesely M.C., Schwartz M., Bermejo D.A., Montes C.L., Cautivo K.M., Kalergis A.M., Rawlings D.J., AcostaRodríguez E.V., Gruppi A. FcγRIIb and BAFF differentially regulate peritoneal B1 cell survival. J. Immunol., 2012, vol. 188, no. 10, pp. 4792–4800.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>10. Bone R.S., Balk R.A.B., Cerra F.B. American college of Chest Physicians. Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guide lines for the use of innovative therapies in sepsis. Crit. Care Med., 1992, vol. 20, no. 6, pp. 864–874.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>11. Carter C.R., Aravind G., Smalle N.L., Cole J.Y., Savic S., Wood P.M. CVID patients with autoimmunity have elevated T cell expression of granzyme B and HLA-DR and reduced levels of Treg cells. J. Clin. Pathol., 2013, vol. 66, no. 2, pp. 146–150.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>12. Griffin D.O., Rothstein T.L. Human B1 cell frequency: isolation and analysis of human B1 cells. Front. Immunol., 2012, vol. 3, pp. 122–123.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>13. Griveas I., Fleva A., Karanikas E., Gogos K., Sakellariou G. CD4/CD8 T-cell ratio in peritoneal dialysis effluents predicts the outcome of peritonitis in patients undergoing continuous ambulatory peritoneal dialysis. Artif. Organs., 2009, vol. 33, no. 12, pp. 1091–1095.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>14. Harris N., Gause W.C. To B or not to B: B cells and the Th2-type immune response to helminthes. Trends Immunol., 2011, vol. 32, no. 2, pp. 80–88.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>15. KiankC.,EntleutnerM.,FürllB.,WesterholtA.,HeideckeC.D.,SchüttC.Stress-inducedimmuneconditioningaffectsthecourse of experimental peritonitis. Shock, 2007, vol. 27, no. 3, pp. 305–311.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>16. Kleinnijenhuis J., Quintin J., Preijers F., Joosten L.A., Jacobs C., Xavier R.J., Van Der Meer J.W., Van Crevel R., Netea M.G. BCG-induced trained immunity in NK cells: role for non-specific protection to infection. Clin. Immunol., 2014, vol. 155, no. 2, pp. 213–219.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>17. Le Gall J.-R., Lemeshow S., Saulnier F. A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA, 1993, vol. 270, pp. 2957–2963.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>18. Lertworapreecha M., Patumraj S., Niruthisard S., Hansasuta P., Bhattarakosol P. Cytotoxic function of gamma delta (gamma/ delta) T cells against pamidronate-treated cervical cancer cells. Indian J. Exp. Biol., 2013, vol. 51, no. 8, pp. 597–605.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>19. Linder M.M., Wacha H., Feldmann U., Wesch G., Streifensand R.A., Gundlach E. Der Mannheimer Peritonitis-Index. Ein Instrument zur intraoperativen Prognose der Peritonitis. Chirurg, 1987, no. 58, pp. 84–91.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>20. Luider J., Cyfra M., Johnson P., Auer I. Impact of the new Beckman Coulter Cytomics FC 500 5-color flow cytometer on a regional flow cytometry clinical laboratory service. Lab. Hematol., 2004, vol. 10, pp. 102–108.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>21. Maecker H., McCoy P., Nussenblatt R. Standardizing immunophenotyping for the human immunology project. Nat. Rev. Immunol., 2012, vol. 12, pp. 191–200.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>22. MarçaisA.,WalzerT.mTOR:agatetoNKcellmaturationandactivation.CellCycle,2014,vol.13,no.21,pp.3315–3316.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>23. McKee S.J., Mattarollo S.R., Leggatt G.R. Immunosuppressive roles of natural killer T (NKT) cells in the skin. J. Leukoc. Biol., 2014, vol. 96, no. 1, pp. 49–54.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>￼24. PillaiM.R.,BixM.EvolutionofIL4andpathogenantagonism.GrowthFactors,2011,vol.29,no.4,pp.153–160.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>25. SistaF.,SchietromaM.,SantisG.D.,MatteiA.,CeciliaE.M.,PiccioneF.,LeardiS.,CarleiF.,AmicucciG.Systemicinflammation and immune response after laparotomy vs laparoscopy in patients with acute cholecystitis, complicated by peritonitis. World J. Gastrointest. Surg., 2013, vol. 5, no. 4, pp. 73–82.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>26. Terabe M., Berzofsky J.A. The immunoregulatory role of type I and type II NKT cells in cancer and other diseases. Cancer Immunol. Immunother., 2014, vol. 63, no. 3, pp. 199–213.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>27. VasudevA.,YingC.T.,AyyadhuryS.,PuanK.J.,AndiappanA.K.,NyuntM.S.,ShadanN.B.,MustafaS.,LowI.,RotzschkeO., Fulop T., Ng T.P., Larbi A. γ/δ T cell subsets in human aging using the classical α/β T cell model. J. Leukoc. Biol., 2014, vol. 96, no. 4, pp. 647–655.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>28. VincentJ.L.,MorenoR.,TakalaJ.,WillattsS.,DeMendonçaA.,BruiningH.,ReinhartC.K.,SuterP.M.,ThijsL.G.TheSOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on SepsisRelated Problems of the European Society of Intensive Care Medicine. Intensive Care Med., 1996, vol. 22, no. 7, pp. 707–710.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>29. WiestR.,KragA.,GerbesA.Spontaneousbacterialperitonitis:recentguidelinesandbeyond.Gut,2012,vol.61,no.2,pp.297–310.</mixed-citation></ref></ref-list></back></article>
